PFGIA
VRTX icon

Patriot Financial Group Insurance Agency’s Vertex Pharmaceuticals VRTX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Sell
3,075
-3,049
-50% -$1.35M 0.16% 166
2026
Q1 		$2.73M Buy
6,124
+3,090
+102% +$1.44M 0.15% 164
2025
Q4 		$1.38M Sell
3,034
-226
-7% -$97.4K 0.16% 155
2025
Q3 		$1.28M Buy
3,260
+184
+6% +$76.9K 0.16% 162
2025
Q2 		$1.37M Buy
3,076
+15
+0.5% +$6.91K 0.16% 161
2025
Q1 		$1.48M Sell
3,061
-405
-12% -$189K 0.2% 129
2024
Q4 		$1.4M Buy
3,466
+82
+2% +$38K 0.19% 122
2024
Q3 		$1.57M Buy
3,384
+302
+10% +$145K 0.21% 110
2024
Q2 		$1.44M Buy
3,082
+37
+1% +$16.1K 0.21% 109
2024
Q1 		$1.27M Buy
3,045
+75
+3% +$31.7K 0.2% 118
2023
Q4 		$1.21M Sell
2,970
-30
-1% -$11.1K 0.23% 107
2023
Q3 		$1.04M Sell
3,000
-9
-0.3% -$3.15K 0.22% 123
2023
Q2 		$1.06M Sell
3,009
-169
-5% -$56.9K 0.2% 120
2023
Q1 		$1M Buy
3,178
+63
+2% +$18.9K 0.2% 118
2022
Q4 		$900K Sell
3,115
-55
-2% -$16.8K 0.12% 119
2022
Q3 		$918K Buy
3,170
+148
+5% +$42.6K 0.22% 112
2022
Q2 		$852K Sell
3,022
-309
-9% -$82.7K 0.17% 129
2022
Q1 		$869K Buy
3,331
+121
+4% +$28.7K 0.15% 144
2021
Q4 		$705K Buy
3,210
+10
+0.3% +$1.95K 0.12% 182
2021
Q3 		$580K Buy
3,200
+2,500
+357% +$488K 0.1% 204
2021
Q2 		$141K Sell
700
-190
-21% -$39.7K 0.03% 524
2021
Q1 		$191K Buy
890
+110
+14% +$24.2K 0.04% 404
2020
Q4 		$184K Buy
780
+287
+58% +$65.8K 0.05% 365
2020
Q3 		$134K Sell
493
-11
-2% -$3.04K 0.04% 340
2020
Q2 		$146K Sell
504
-17
-3% -$4.61K 0.06% 279
2020
Q1 		$124K Buy
521
+246
+89% +$56.4K 0.06% 290
2019
Q4 		$60K Buy
275
+98
+55% +$19.8K 0.02% 442
2019
Q3 		$30K Hold
177
– – 0.01% 548
2019
Q2 		$32K Buy
177
+96
+119% +$16.8K 0.01% 533
2019
Q1 		$15K Buy
81
+79
+3,950% +$14.6K 0.01% 623
2018
Q4 		$0 Hold
2
– – ﹤0.01% 1119
2018
Q3 		$1K Buy
+2
New +$356 ﹤0.01% 956
2017
Q4 		– Sell
-16
Closed -$2K – 968
2017
Q3 		$2K Buy
+16
New +$2.41K ﹤0.01% 849

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Patriot Financial Group Insurance Agency's VRTX Position: Q2 2026 in Review

Patriot Financial Group Insurance Agency reduced its Vertex Pharmaceuticals (VRTX) stake by 50% in Q2 2026, selling an estimated $1.35M and leaving 3,075 shares worth $1.53M. The position accounts for 0.16% of the portfolio, ranked #166.

Patriot Financial Group Insurance Agency first reported a position in VRTX in Q3 2017 and has held it in 33 quarters since. The position peaked at $2.73M in Q1 2026. 1,090 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Patriot Financial Group Insurance Agency held 3,075 shares of Vertex Pharmaceuticals worth $1.53M as of Q2 2026.
  • Patriot Financial Group Insurance Agency sold 3,049 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.35M.
  • Vertex Pharmaceuticals made up 0.16% of Patriot Financial Group Insurance Agency's portfolio in Q2 2026, its #166 holding.
  • Patriot Financial Group Insurance Agency first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 33 quarters since.
  • Patriot Financial Group Insurance Agency's Vertex Pharmaceuticals position peaked at $2.73M in Q1 2026.
  • 1,090 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2026, filed 16 Jul 2026.